Improvement in the determination of HIV-1 tropism using the V3 gene sequence and a combination of bioinformatic tools

Journal of Medical Virology

Volumn 81, Issue 5, 2009, Pages 763-767

  Chueca, Natalia ^a   Garrido, Carolina ^b   Álvarez, Marta ^a   Poveda, Eva ^b   Luna, Juan De Dios ^a   Zahonero, Natalia ^b   Hernández Quero, José ^a   Soriano, Vicente ^b   Maroto, Carmen ^a   De Mendoza, Carmen ^b   García, Federico ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

CCR5; Co receptor; HIV; Maraviroc; Tropism

Indexed keywords

CHEMOKINE RECEPTOR CXCR4;

ARTICLE; BIOINFORMATICS; DATA BASE; GENE SEQUENCE; GENETIC ALGORITHM; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS 1; PHENOTYPE; PREDICTION; SCREENING; SENSITIVITY AND SPECIFICITY; VIRUS CLASSIFICATION; VIRUS DETECTION;

ALGORITHMS; CELL LINE; COMPUTATIONAL BIOLOGY; GENOTYPE; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; PEPTIDE FRAGMENTS; PHENOTYPE; RECEPTORS, CCR5; RECEPTORS, CXCR4; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; TROPISM;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 65649150328     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21425     Document Type: Article

References (28)

1. Beerenwinkel N, Sing T, Lengauer T, Rahnenfuhrer J, Roomp K, Savenkov I, Fischer R, Hoffmann D, Selbig J, Korn K, Walter H, Berg T, Braun P, Fätkenheuer G, Oette M, Rockstroh J, Kupfer B, Kaiser R, Däumer M. 2005. Computational methods for the design of effective therapies against drug resistant HIV strains. Bioinformatics 21:3943-3950.
2. Berger E, Doms R, Fenyö E, Korber B, Littman D, Moore J, Sattentau Q, Schuitemaker H, Sodroski J, Weiss R. 1998. A new classification for HIV-1. Nature 391:240-240
3. Connor R, Sheridan K, Ceradini D, Choe S, Landau N. 1997. Change in coreceptor use coreceptor use correlates with disease progression in HIV-1 infected individuals. J Exp Med 185:621-628.
4. Cormier E, Dragic T. 2002. The crown and stem of the V3 loop play distinct roles in HIV type 1 envelope glycoprotein interactions with the CCR5 coreceptor. J Virol 76:8953-8957.
5. de Mendoza C, Rodríguez C, García F, Eiros JM, Ruiz L, Caballero E, Aguilera A, Leiva P, Colomina J, Gutiérrez F, del Romero J, Agüero J, Soriano V, Spanish HIV Seroconverter Study Group. 2007. Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance. J Antimicrob Chemother 59:698-704.
6. Delobel P, Nugeyre M, Cazabat M, Pasquier C, Marchou B, Massip P, Barre-Sinoussi F, Israël N, Izopet J. 2007. Population-based sequencing of V3 env for predicting the coreceptor usage of HIV-1 quasiespecies. J Clin Microbiol 45:1572-1580.
7. Garrido C, Roulet V, Chueca N, Poveda E, Aguilera A, Skrabal K, Zahonero N, Carlos S, García F, Faudon JL, Soriano V, de Mendoza C. 2008. Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes. J Clin Microbiol 46:887-891.
8. Goodenow M, Collman R. 2006. HIV-1 coreceptor preference is distinct from target cell tropism: A dual-parameter nomenclature to define viral phenotypes. J Leukoc Biol 80:965-972.
9. Jensen M, van't Wout A. 2003. Predicting HIV-1 coreceptor usage with sequence analysis. AIDS Rev 5:104-112.
10. Jensen M, Li F, van't Wout A, Nickle D, Shriner D, He H, McLaughlin S, Shankarappa R, Margolick JB, Mullins JI. 2003. Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of HIV type 1 env V3 loop sequences. J Virol 77:13376-13388.
11. Lewis M, Mori J, Simpson P, Whitcomb J, Li X, Robertson D, Westby M. 2008. Changes in V3 loop sequences associated with failure of Maraviroc treatment in patients enrolled in the MOTIVATE 1 and 2 trials. 15th Conference on Retroviruses and Opportunistic Infections. February 3-6. Boston, MA. [Abstract 871].
12. Low A, Dong W, Chan D, Sing T, Swanstrom R, Jensen M, Pillai S, Good B, Harrigan PR. 2007. Current V3 genotyping algorithms are inadequate for predicting X4 coreceptor usage in clinical isolates. AIDS 21:F17-F24.
13. Meanwell N, Kadow J. 2007. Maraviroc, a chemokine CCR5 receptor antagonist for the treatment of HIV infection and AIDS. Curr Opin Investig Drugs 8:669-681.
14. Mueller M, Bogner J. 2007. Treatment with CCR5 antagonists: Which patient may have a benefit? Eur J Med Res 12:441-452.
15. Pearson W. 1990. Rapid and sensitive sequence comparison with FASTP and FASTA. Methods Enzymol 183:63-98.
16. Pillai S, Good B, Richman D, Corbeil J. 2003. A new perspective on V3 phenotype prediction. AIDS Res Hum Retroviruses 19:145-149.
17. Poveda E, Briz V, Quinones-Mateu M, Soriano V. 2006. HIV tropism: Diagnostic tools and implications for disease progression and treatment with entry inhibitors. AIDS 20:1359-1367.
18. Poveda E, Briz V, Roulet V, González M, Faudon J, Skrabal K, González M, Soriano V. 2007. Correlation between a phenotypic assay and three bioinformatics tools for determining HIV co-receptor use. AIDS 21:1487-1490.
19. Roulet V, Faudon JL, Rochas S, Labernardière J-L, Mammano F, Lebel-Binay S, Skrabal K. 2007. Sensitive assay for the determination of viral tropism suitable for clinical management of HIV subtype b and non-B infected individuals treated with coreceptor antagonists: Phenoscript1 env. Antivir Ther 12:S162.
20. Rusconi S, Scozzafava A, Mastrolorenzo A, Supuran C. 2007. An update in the development of HIV entry inhibitors. Curr Top Med Chem 7:1273-1289.
21. Schuitemaker H, Koot M, Kootstra N, Dercksen M, de Goede R, van Steenwijk R, Lange J, Schattenkerk J, Miedema F, Tersmette M. 1992. Biological phenotype of HIV type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J Virol 66:1354-1360.
22. Sing T, Low A, Beerenwinkel N, Sander O, Cheung P, Domingues F, Büch J, Däumer M, Kaiser R, Lengauer T, Harrigan P. 2007. Predicting HIV coreceptor usage on the basis of genetic and clinical covariates. Antivir Ther 12:1097-1106.
23. Skrabal K, Low A, Dong W, Sing T, Cheung P, Mammano F, Harrigan R. 2007. Determining HIV coreceptor use in a clinical setting: Degree of correlation between two phenotypic assays and a bioinformatic model. J Clin Microbiol 45:279-284.
24. Soulié C, Derache A, Aimé C, Marcelin AG, Garcelain G, Simon A, Katlama C, Calvez V. 2008. Comparison of two genotypic algorithms to determine HIV-1 tropism. HIV Med 9:1-5.
25. Van Baelen K, Vandenbroucke I, Rondelez E, Van Eygen V, Vermeiren H, Stuyver L. 2007. HIV-1 coreceptor usage determination in clinical isolates using clonal and population-based genotypic and phenotypic assays. J Virol Methods 146:61-73.
26. Weber J, Piontkivska H, Quinones-Mateu M. 2006. HIV type 1 tropism and inhibitors of viral entry: Clinical implications. AIDS Rev 8:60-77.
27. Whitcomb J, Huang W, Fransen S, Limoli K, Toma J, Wrin T, Chappey C, Kiss LD, Paxinos EE, Petropoulos C. 2007. Development and characterization of a novel single-cycle recombinant-virus assay to determine HIV type 1 coreceptor tropism. Antimicrob Agents Chemother 51:566-575.
28. Yang Z, Chakrabarti B, Xu L, Welcher B, Kong W, Leung K, Panet A, Mascola J, Nabel G. 2004. Selective modification of variable loops alters tropism and enhances immunogenicity of HIV-1 envelope. J Virol 78:4029-4036.